Hypolipidemia in patients with chronic hepatitis C virus infection and its relation to child-pugh classification

Evaluation of the risk of atherosclerosis in chronic hepatitis C patients

Fluvastatin as an adjuvant therapy with pegylated Interferon and Ribavirin in the treatment of chronic hepatitis C virus

Atherosclerosis and cardiomyopathy in patients with HCV liver cirrhosis

Correlation between lipid profile and rapid virological response to treatment of hepatitis C virus genotype IV with pegylated interferon alpha and ribavirin

Factors associated with liver steatosis in chronic hepatitis C patients

Endothelial dysfunction in patients with chronic hepatitis C virus infection

Cardiac changes in cirrhotic patients with chronic HCV

The magnitude of steatosis in non -obese patients with chronic HCV

The impact of statins on EPCS in patients with coronary artery disease